Arcadia Biosciences, Inc. - Common Stock (RKDA)
4.8000
-0.0500 (-1.03%)
Arcadia Biosciences Inc is a biotechnology company focused on developing and commercializing innovative agricultural solutions aimed at improving crop performance and sustainability
The company specializes in utilizing its proprietary technologies to enhance the nutritional and agronomic traits of various crops, leading to significant benefits for farmers and consumers. By leveraging advanced genetic tools and insights, Arcadia is committed to addressing global food challenges, promoting environmental stewardship, and fostering healthier food options through its diverse portfolio of products.
![](https://cdn.benzinga.com/files/images/story/2024/12/05/oil-prices-5079975.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/05/Neurocrine-Biosciences.jpeg?width=1200&height=800&fit=crop)
Shares of Arcadia Biosciences, Inc. (NASDAQRKDA) are trading higher Thursday following the company's announcement of an all-stock merger with Roosevelt Resources LP. Here's what you need to know.
Via Benzinga · December 5, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!
Via InvestorPlace · August 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
RKDA stock results show that Arcadia Biosciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024
![](https://cdn.benzinga.com/files/images/story/2024/02/06/image45.jpg?width=1200&height=800&fit=crop)
The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · February 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 2, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Universal Stainless (NASDAQUSAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via Benzinga · March 28, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 4, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
On Thursday, 369 companies hit new 52-week lows.
Via Benzinga · October 5, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/30/image28.jpeg?width=1200&height=800&fit=crop)
Gainers AgileThought, Inc. (NASDAQAGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday.
Via Benzinga · August 30, 2023
![](https://cdn.benzinga.com/files/images/story/2023/07/20/rkda.png?width=1200&height=800&fit=crop)
Plant-based health and wellness products producer Arcadia Biosciences Inc (NASDAQRKDA) said it looks
Via Benzinga · July 20, 2023
![](https://cdn.benzinga.com/files/images/story/2023/05/23/image10.jpg?width=1200&height=800&fit=crop)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Via Benzinga · May 23, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_222.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Creative Realities (NASDAQCREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via Benzinga · March 30, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via Benzinga · August 10, 2023
![](https://cdn.benzinga.com/files/images/story/2023/07/17/image21.jpeg?width=1200&height=800&fit=crop)
Gainers ProMIS Neurosciences, Inc. (NASDAQPMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.
Via Benzinga · July 17, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1856.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSETAK) is likely to report earnings for its fourth quarter. • Exela Technologies NASDAQ:XELANASDAQXELA)
Via Benzinga · May 11, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_7533.jpeg?width=1200&height=800&fit=crop)
During Thursday's session, 99 companies made new 52-week lows.
Via Benzinga · April 20, 2023